RESUMEN
BACKGROUND: In October 2006, the heptavalent pneumococcal conjugate vaccine was included in the Madrid vaccination calendar, warranting serotype (St) surveillances in pneumococcal pediatric parapneumonic empyema (PPE). METHODS: A prospective 2-year (May 2007-April 2009) laboratory-confirmed PPE surveillance was performed in 22 hospitals. All isolates (for serotyping) and culture-negative pleural fluids were sent to the reference laboratory for polymerase chain reaction (PCR) analysis. RESULTS: We identified 138 PPEs. Pneumococcal etiology was confirmed in 100 cases: 38 by culture, 62 by PCR. Mean age was 44.64 ± 26.64 months; 51.0% were male. Similar pneumococcal PPE distribution was found by age: 21% to 28% in <24, ≥24-<36, ≥36-<60, and ≥60 months. PPE-associated Sts were St 1 (38%), St 5 (15%), St 19A (11%), St 7F (9%), St 3 (8%), and others (19%). St 1 was the most common in >36 months, with similar rates to St 19A in <24 months (≈30%). In ≥24-≤36 months, St 3 (21.7%), St 1 and St 5 (17.4% each) were the most frequent. No differences in demographic data, vaccination status, length of hospitalization, and outcome were found between culture-negative (PCR positive) and culture-positive PPE patients, with significantly higher percentages of St 1 and St 5 in culture-positive PPEs. Total rates of St 1 (38%), St 5 (15%), and St 7F (9%) would have been over-represented considering only positive-culture PPEs (n = 38), by increasing to 52.6% (St 1), 23.7% (St 5), and 10.5% (St 7F). The 13-valent pneumococcal conjugate vaccine would cover 84.0% of Sts causing PPEs. CONCLUSIONS: PCR is essential for determining the specific etiology of PPE.
Asunto(s)
Empiema/epidemiología , Empiema/microbiología , Infecciones Neumocócicas/epidemiología , Infecciones Neumocócicas/microbiología , Vacunas Neumococicas/administración & dosificación , Streptococcus pneumoniae/clasificación , Streptococcus pneumoniae/aislamiento & purificación , Preescolar , Femenino , Vacuna Neumocócica Conjugada Heptavalente , Humanos , Lactante , Masculino , Vacunas Neumococicas/inmunología , Reacción en Cadena de la Polimerasa , Prevalencia , Estudios Prospectivos , Serotipificación , España/epidemiologíaRESUMEN
BACKGROUND: Tuberculosis causes significant morbidity and mortality worldwide. In the last years, international travel and immigration have led to important changes in the epidemiology of this disease. Drug resistance has emerged as an important threat to tuberculosis control. Data regarding the impact of immigration and the incidence of drug-resistant strains in children are lacking. METHODS: Retrospective review of patients diagnosed with pulmonary tuberculosis at La Paz Children's Hospital in a 30-year period. Data were collected with regard to the clinical, radiologic, microbiologic, and demographic characteristics of patients, and data from the 3 decades of the study were compared using chi test and Fisher exact test. RESULTS: A total of 507 cases of tuberculosis were identified, 414 of which had pulmonary involvement. During the study, there was a significant decrease in tuberculous meningitis: 10.4% in 1978-1987, 5.6% in 1988-1997, and 2.9% in 1998-2007 (P < 0.05). The most frequent reason for a consultation was case contact investigation. The adult source case was identified in 64% of patients. We observed an increase in extrafamilial contacts (8% in 1978-1987 and 18% in 1998-2007, P < 0.01), including 4 cases of immigrant caretakers. Tuberculosis in immigrant children has increased with time: 2% in the period 1978-1987, 6% in 1988-1997, and 46% in 1998-2007 (P < 0.001). The primary resistance rate to isoniazid in our population was 6.5%. CONCLUSIONS: Tuberculosis in our area continues to be a major health problem, especially among foreign-born children. As drug-resistant strains are increasing, initial therapy with 4 drugs is recommended in our population.
Asunto(s)
Emigración e Inmigración , Tuberculosis Pulmonar/epidemiología , Adolescente , Antituberculosos/farmacología , Niño , Preescolar , Trazado de Contacto , Farmacorresistencia Bacteriana , Femenino , Humanos , Lactante , Recién Nacido , Isoniazida/farmacología , Masculino , Estudios Retrospectivos , España/epidemiología , Tuberculosis Meníngea/epidemiología , Tuberculosis Pulmonar/microbiología , Tuberculosis Pulmonar/patologíaRESUMEN
Treatment of cutaneous leishmaniasis is sometimes difficult. No single ideal therapy has yet been identified and some of the drugs that are currently used are associated with significant toxicity. We present two cases of cutaneous leishmaniasis in children, one caused by Leishmania infantum and the other by Leishmania braziliensis. Both of them were successfully treated with intravenous liposomal amphotericin B.
Asunto(s)
Anfotericina B/administración & dosificación , Antiprotozoarios/administración & dosificación , Leishmania braziliensis/efectos de los fármacos , Leishmania infantum/efectos de los fármacos , Leishmaniasis Cutánea/tratamiento farmacológico , Niño , Humanos , Lactante , Leishmaniasis Cutánea/parasitología , Leishmaniasis Cutánea/patología , Liposomas , Masculino , Reacción en Cadena de la Polimerasa , Resultado del TratamientoRESUMEN
Acute otitis media (AOM) is one of the most common childhood diseases and the main reason for prescribing antibiotics in developed countries. Indiscriminate treatment of children with an inconclusive diagnosis has favored the development of resistance, and this has led to the creation of clinical guidelines to promote judicious antibiotic use. AOM has shown high rates of spontaneous resolution and minimal benefits from antibiotics; hence a policy of observation for 48-72 hours before initiating treatment is justified in many children. In recent years, attention has been focused on developing effective vaccines against the most common causative pathogens, Streptococcus pneumoniae and Haemophilus influenzae. The H. influenzae type b conjugate vaccine has little impact on AOM since most strains are nontypable. The 7-valent pneumococcal conjugate vaccine has an efficacy of 55% in AOM caused by vaccine serotypes, but replacement with nonvaccine serotypes and nontypable H. influenzae reduce the overall efficacy of the vaccine to 6-8%. An overall decrease of pneumococcal resistance to penicillin has been seen in vaccinated children, but there is a trend to an increase in antibiotic resistance in non-vaccine serotypes. High-dose amoxicillin is the treatment of choice for AOM, but the increase of H. influenzae in pneumococcal-vaccinated children may require reconsideration of this recommendation in forthcoming guidelines.
Asunto(s)
Otitis Media/prevención & control , Vacunas Neumococicas , Vacunación/estadística & datos numéricos , Enfermedad Aguda , Antibacterianos/uso terapéutico , Cápsulas Bacterianas , Farmacorresistencia Bacteriana Múltiple , Infecciones por Haemophilus/complicaciones , Infecciones por Haemophilus/epidemiología , Infecciones por Haemophilus/prevención & control , Vacunas contra Haemophilus , Haemophilus influenzae/clasificación , Haemophilus influenzae/inmunología , Humanos , Otitis Media/tratamiento farmacológico , Otitis Media/epidemiología , Otitis Media/microbiología , Infecciones Neumocócicas/complicaciones , Infecciones Neumocócicas/epidemiología , Infecciones Neumocócicas/prevención & control , Factores de Riesgo , Streptococcus pneumoniae/inmunologíaRESUMEN
AIM: To analyze the clinical spectrum and the incidence of coronary involvement in infants with typical Kawasaki's disease (KD). PATIENTS AND METHODS: A retrospective study was performed on children one year of age or younger diagnosed from February 1992 to January 2006 with typical KD. Children with incomplete forms of the disease were not included. RESULTS: Twenty-five infants were diagnosed with KD during the study period. The median age of the patients was 10 months (range, 4-12 months). All children but one received intravenous gammaglobulin (IVIG), 84% before the 10th day of disease. Seven patients (28%) required the administration of more than one dose of IVIG, because persistence of fever. Coronary artery disease (CAD) was recorded in 6 cases (24%), five of them being boys. All patients with CAD were treated with ASA plus IVIG and 84% of them received this therapy within the first 10 days of the KD onset. CONCLUSIONS: In spite of the exclusion of our study of incomplete presentations and of an early administration of IVIG in our patients, we have observed a high rate of infants who developed CAD, which is similar to the one reported in children who do not receive IVIG.
Asunto(s)
Enfermedad de la Arteria Coronaria/etiología , Inmunoglobulinas Intravenosas/uso terapéutico , Factores Inmunológicos/uso terapéutico , Síndrome Mucocutáneo Linfonodular/complicaciones , Síndrome Mucocutáneo Linfonodular/tratamiento farmacológico , Niño , Preescolar , Femenino , Humanos , Masculino , Síndrome Mucocutáneo Linfonodular/diagnóstico , Estudios RetrospectivosRESUMEN
OBJECTIVES: The objective was to present a novel technique for antrostomy performed before sinus elevation in atrophic maxilla for subsequent implant placement. MATERIAL AND METHODS: The study included 10 sinus elevations performed by the proposed technique in nine consecutive patients presenting with inadequate posterior maxillary height. The technique is described, calculating the antrostomy surface area, volume of bone tissue obtained and final height attained in each case. A total of 16 implants were placed. RESULTS: All ten elevations were accomplished. Mean antrostomy surface area was 0.55 mm2, mean bone volume obtained was 0.56 cm3 and mean height attained was 11.7 mm from a baseline mean height of 5.6 mm. Out of the 16 implants, 14 were inserted immediately after the elevation and 2 were inserted in a second step, after ossification; 93.7% of the implants were osseointegrated at 6 months after prosthesis placement. CONCLUSION: The use of bone scrapers to create antrostomy for sinus elevation is a simple and very safe procedure. It provides a variable amount of particulate bone graft that is easily handled and highly useful for packing the cavity that will elevate the sinus membrane.
Asunto(s)
Trasplante Óseo/instrumentación , Trasplante Óseo/métodos , Implantación Dental Endoósea/métodos , Maxilar/patología , Maxilar/cirugía , Atrofia , Diseño de Equipo , Femenino , Humanos , MasculinoRESUMEN
No disponible
Objectives: The objective was to present a novel technique for antrostomy performed before sinus elevation in atrophic maxilla for subsequent implant placement.Material and methods: The study included 10 sinus elevations performed by the proposed technique in nine consecutive patients presenting with inadequate posterior maxillary height. The technique is described, calculating the antrostomy surface area, volume of bone tissue obtained and final height attained in each case. A total of 16 implants were placed.Results: All ten elevations were accomplished. Mean antrostomy surface area was 0.55 mm2, mean bone volume obtained was 0.56 cm3 and mean height attained was 11.7 mm from a baseline mean height of 5.6 mm. Out of the 16 implants, 14 were inserted immediately after the elevation and 2 were inserted in a second step, after ossification; 93.7% of theimplants were osseointegrated at 6 months after prosthesis placement.Conclusion: The use of bone scrapers to create antrostomy for sinus elevation is a simple and very safe procedure. It provides a variable amount of particulate bone graft that is easily handled and highly useful for packing the cavity that will elevate the sinus membrane
Asunto(s)
Humanos , Anomalías Maxilomandibulares/cirugía , Implantación Dental/métodos , Seno Maxilar/anomalías , Seno Maxilar/cirugía , Procedimientos Quirúrgicos Orales/métodosAsunto(s)
Astrágalo , Tuberculosis Resistente a Múltiples Medicamentos , Tuberculosis Osteoarticular , Antituberculosos/administración & dosificación , Antituberculosos/uso terapéutico , Preescolar , Quimioterapia Combinada , Etambutol/administración & dosificación , Etambutol/uso terapéutico , Femenino , Estudios de Seguimiento , Hospitalización , Humanos , Imagen por Resonancia Magnética , Pirazinamida/administración & dosificación , Pirazinamida/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento , Tuberculosis Resistente a Múltiples Medicamentos/diagnóstico , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Osteoarticular/diagnóstico , Tuberculosis Osteoarticular/tratamiento farmacológicoRESUMEN
In March 2005, the Centers for Disease Control and Prevention (CDC) investigated a large hemorrhagic fever (HF) outbreak in Uige Province in northern Angola, West Africa. In total, 15 initial specimens were sent to CDC, Atlanta, Ga., for testing for viruses associated with viral HFs known to be present in West Africa, including ebolavirus. Marburgvirus was also included despite the fact that the origins of all earlier outbreaks were linked directly to East Africa. Surprisingly, marburgvirus was confirmed (12 of 15 specimens) as the cause of the outbreak. The outbreak likely began in October 2004 and ended in July 2005, and it included 252 cases and 227 (90%) fatalities (report from the Ministry of Health, Republic of Angola, 2005), making it the largest Marburg HF outbreak on record. A real-time quantitative reverse transcription-PCR assay utilized and adapted during the outbreak proved to be highly sensitive and sufficiently robust for field use. Partial marburgvirus RNA sequence analysis revealed up to 21% nucleotide divergence among the previously characterized East African strains, with the most distinct being Ravn from Kenya (1987). The Angolan strain was less different ( approximately 7%) from the main group of East African marburgviruses than one might expect given the large geographic separation. To more precisely analyze the virus genetic differences between outbreaks and among viruses within the Angola outbreak itself, a total of 16 complete virus genomes were determined, including those of the virus isolates Ravn (Kenya, 1987) and 05DRC, 07DRC, and 09DRC (Democratic Republic of Congo, 1998) and the reference Angolan virus isolate (Ang1379v). In addition, complete genome sequences were obtained from RNAs extracted from 10 clinical specimens reflecting various stages of the disease and locations within the Angolan outbreak. While the marburgviruses exhibit high overall genetic diversity (up to 22%), only 6.8% nucleotide difference was found between the West African Angolan viruses and the majority of East African viruses, suggesting that the virus reservoir species in these regions are not substantially distinct. Remarkably few nucleotide differences were found among the Angolan clinical specimens (0 to 0.07%), consistent with an outbreak scenario in which a single (or rare) introduction of virus from the reservoir species into the human population was followed by person-to-person transmission with little accumulation of mutations. This is in contrast to the 1998 to 2000 marburgvirus outbreak, where evidence of several virus genetic lineages (with up to 21% divergence) and multiple virus introductions into the human population was found.
Asunto(s)
Brotes de Enfermedades , Genoma Viral/genética , Enfermedad del Virus de Marburg/genética , Enfermedad del Virus de Marburg/mortalidad , Marburgvirus/genética , Mutación , Angola/epidemiología , Secuencia de Bases , Brotes de Enfermedades/historia , Femenino , Historia del Siglo XXI , Humanos , Kenia/epidemiología , Masculino , Enfermedad del Virus de Marburg/historia , Enfermedad del Virus de Marburg/transmisión , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ARN , Especificidad de la EspecieAsunto(s)
Infecciones por Citomegalovirus/diagnóstico , Neumonía Viral/diagnóstico , Microglobulina beta-2/líquido cefalorraquídeo , Biomarcadores/análisis , Infecciones por Citomegalovirus/tratamiento farmacológico , Estudios de Seguimiento , Ganciclovir/uso terapéutico , Humanos , Recién Nacido , Infusiones Intravenosas , Masculino , Atención Perinatal , Neumonía Viral/tratamiento farmacológico , Medición de Riesgo , Índice de Severidad de la Enfermedad , Resultado del TratamientoRESUMEN
A 12-year-old immunocompromised boy was hospitalized because of invasive aspergillosis with lung and central nervous system involvement. He was treated with surgery and liposomal amphotericin B, but he developed a pulmonary empyema and a bronchopleural-cutaneous fistula. A catheter was placed through the fistula, and amphotericin B (up to 50 mg in 10 ml of 5% dextrose) was instilled daily into the pleural cavity for 45 days. Treatment was well-tolerated, and the empyema resolved completely, with no evidence of recurrence after 2 years of follow-up.
Asunto(s)
Anfotericina B/administración & dosificación , Aspergilosis/diagnóstico , Empiema Pleural/diagnóstico , Empiema Pleural/tratamiento farmacológico , Fungemia/diagnóstico , Aspergilosis/complicaciones , Niño , Empiema Pleural/complicaciones , Estudios de Seguimiento , Fungemia/complicaciones , Humanos , Huésped Inmunocomprometido , Infusiones Intravenosas , Inyecciones Intralesiones , Imagen por Resonancia Magnética , Masculino , Medición de Riesgo , Tomografía Computarizada por Rayos X , Resultado del TratamientoAsunto(s)
Encefalitis por Varicela Zóster/diagnóstico , Herpes Zóster/diagnóstico , Aciclovir/uso terapéutico , Adolescente , Antivirales/uso terapéutico , Diagnóstico Diferencial , Electroencefalografía , Encefalitis por Varicela Zóster/tratamiento farmacológico , Fiebre/etiología , Cefalea/etiología , Herpes Zóster/complicaciones , Herpes Zóster/tratamiento farmacológico , Humanos , Masculino , Trastornos Migrañosos/diagnóstico , Fotofobia/etiología , Vómitos/etiologíaRESUMEN
Acute Coxiella burnetii infection is most commonly a mild and self-limiting disease with fever, pneumonia and hepatitis. Endocarditis is the most frequent clinical presentation of chronic infection. We report a 2-year-old child with Q fever who presented with acute pericarditis and cardiac tamponade and who developed a chronic hepatic infection.
Asunto(s)
Coxiella burnetii/aislamiento & purificación , Hepatitis Crónica/microbiología , Pericarditis/microbiología , Fiebre Q/diagnóstico , Antibacterianos , Taponamiento Cardíaco/complicaciones , Taponamiento Cardíaco/diagnóstico , Taponamiento Cardíaco/terapia , Preescolar , Terapia Combinada , Progresión de la Enfermedad , Quimioterapia Combinada/administración & dosificación , Femenino , Estudios de Seguimiento , Hepatitis Crónica/complicaciones , Hepatitis Crónica/diagnóstico , Hepatitis Crónica/terapia , Humanos , Pruebas de Función Hepática , Insuficiencia Multiorgánica/complicaciones , Insuficiencia Multiorgánica/diagnóstico , Insuficiencia Multiorgánica/terapia , Pericarditis/complicaciones , Pericarditis/diagnóstico , Pericarditis/terapia , Fiebre Q/complicaciones , Respiración Artificial , Índice de Severidad de la Enfermedad , Choque Cardiogénico/complicaciones , Choque Cardiogénico/diagnóstico , Choque Cardiogénico/terapiaRESUMEN
OBJECTIVES: To compare the frequency, clinical and radiologic manifestations and source of infection of pulmonary tuberculosis in children treated in our hospital during two decades (1978 through 1987 and 1988 through 1997) and to evaluate the influence of the emergence of HIV infection (since 1985) and the effect of the discontinuation of Calmette-Guérin bacillus (BCG) vaccination (since 1987) on childhood tuberculosis. METHODS: We reviewed 324 children diagnosed with pulmonary tuberculosis in our hospital during the 20 years (1978 through 1997). The data from 2 decades, 1978 through 1987 and 1988 through 1997, were compared. BCG vaccination in Spain was discontinued in 1987, and HIV infection emerged significantly as a public health problem. RESULTS: An increase in the number of children with single hilar adenopathy was observed (32.2% in 1978 through 1987 vs. 43.4%, in 1988 through 1997, P < 0.05) in comparison with those with parenchymal involvement or a mixed pattern (62.4% in 1978 through 1987 vs. 45.7% in 1988 to 1997). Frequency in extrapulmonary manifestations in both periods was similar, with a nonsignificant trend toward a lower rate of tuberculous meningitis in the latter decade (10.4 vs. 5.6%, P = 0.07). We were able to identify an adult source case for 67.1% of the children (100 of 149) in the first decade vs.58.3% (102 of 175) in the second (P = NS); 10.8% of adult contacts but only 2.3% of children (all of them in the second period) were HIV-positive. CONCLUSIONS: Discontinuation of BCG vaccination and emergence of HIV infection have had little influence on childhood tuberculosis in our area.